Linden Advisors’s Lam Research LRCX Stock Holding History

Linden Advisors’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-550,000	Closed	-$26M	–	732
2020 Q4	$26M	Buy	+550,000	New	+$23.1M	0.19%	81

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Linden Advisors's LRCX Position: Q1 2021 in Review

Linden Advisors sold out of Lam Research (LRCX) in Q1 2021, closing a stake of 550,000 shares — an estimated $26M sold.

Linden Advisors first reported a position in LRCX in Q4 2020 and held it in 1 quarter. The position peaked at $26M in Q4 2020. 1,259 funds tracked by Wall St. Rank hold LRCX as of Q1 2021.

Linden Advisors reported no remaining Lam Research position as of Q1 2021 after selling out during the quarter.
Linden Advisors sold 550,000 Lam Research shares in Q1 2021, an estimated $26M.
Linden Advisors first reported a position in Lam Research in Q4 2020 and held it in 1 quarter.
Linden Advisors's Lam Research position peaked at $26M in Q4 2020.
1,259 funds tracked by Wall St. Rank held Lam Research as of Q1 2021.

Based on Linden Advisors's 13F filing for Q1 2021, filed 17 May 2021.